Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine in Periodontal Surgical Procedures
NCT07725731Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2024
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Post-operative pain measured with Numeric Rating Scale NRS-21 pain scale. Started Oct 2024; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07725731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07725731.